A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers
Status:
Completed
Trial end date:
2022-12-07
Target enrollment:
Participant gender:
Summary
This trial is designed to compare the rate and extent of absorption of four different
formulations of zavegepant. 52 healthy male and female volunteers will receive a single dose
of each formulation at least 7 days apart over a period of about 7 weeks and the amount of
drug in their blood will be assessed over the 24 hour period after each dose.